Assignee profile:

ENLIVEX THERAPEUTICS LTD.

City:

Jerusalem

Country:

Israel

Published Applications:

10

Last publication date:

2020-02-27

Patent Grants:

10

Last grant date:

2022-11-15

Top Inventors for applications by ENLIVEX THERAPEUTICS LTD.

These are the the leading inventors for applications assigned to ENLIVEX THERAPEUTICS LTD.:

Recent patent applications by ENLIVEX THERAPEUTICS LTD.

ENLIVEX THERAPEUTICS LTD. based in Jerusalem, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-02-27 ✅ Patent 11,497,767 granted on 2022-11-15
US20200061116A1
Human necessities

Combination immune therapy and cytokine control therapy for cancer treatment

#2 | 2020-01-09 ✅ Patent 11,951,126 granted on 2024-04-09
US20200009192A1
Human necessities

Therapeutic apoptotic cells for cancer therapy

#3 | 2020-01-09 ✅ Patent 11,717,539 granted on 2023-08-08
US20200009191A1
Human necessities

Combination immune therapy and cytokine control therapy for cancer treatment

#4 | 2019-03-21 ✅ Patent 11,304,976 granted on 2022-04-19
US20190083535A1
Human necessities

Combination immune therapy and cytokine control therapy for cancer treatment

#5 | 2019-01-24 ✅ Patent 10,927,343 granted on 2021-02-23
US20190024048A1
Chemistry; metallurgy

Therapeutic apoptotic cell preparations, method for producing same and uses thereof

#6 | 2018-04-19 ✅ Patent 10,857,181 granted on 2020-12-08
US20180104277A1
Human necessities

Therapeutic pooled blood apoptotic cell preparations and uses thereof

#7 | 2018-04-05 ✅ Patent 11,512,289 granted on 2022-11-29
US20180094244A1
Chemistry; metallurgy

Combination immune therapy and cytokine control therapy for cancer treatment

#8 | 2017-12-21 ✅ Patent 11,000,548 granted on 2021-05-11
US20170360836A1
Human necessities

Combination immune therapy and cytokine control therapy for cancer treatment

#9 | 2015-10-01 ✅ Patent 10,077,426 granted on 2018-09-18
US20150275175A1
Chemistry; metallurgy

Therapeutic apoptotic cell preparations, method for producing same and uses thereof

#10 | 2015-02-26 ✅ Patent 9,567,568 granted on 2017-02-14
US20150056678A1
Chemistry; metallurgy

Method of preparing apoptotic monocytes

Also check out ENLIVEX THERAPEUTICS LTD.'s (Jerusalem, Israel) applicant profile with 3 patent applications submitted.

AssigneeID:

130174 ⎘